1[3]Hedblad B,Wiketrand J,Janzor L,et al.Low-Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media Thickness.Main Results From the β-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).Circulation,2001,103 (13):1721-1726
2[4]Wiklund O,HultheJ,Wikstrand J,et al.Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hyperoholesterolemia:a 3-year randomized study.Stroke,2002,33 (2):572-577
3[5]Wikstrand J,Warnold I,Olsson G,et al.Primary prevention with metoprolol in patients with hypertension.Mortality results from Metoprolol Athersosclerosis Prevention in Hypertension (MAPHY) Study.JAMA,1988,259 (13):1976
5[7]MERIT-HF Study Guoup.Effect of meloprolol CR/XL in chronic heart failure:Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF).Lancet,1999,353(9169):2001-2007
6[8]Gillman MW,Kannel WB,Belanger A,et al.Influence of heart rate on mortality among persons with hypertension:the Framingham Study.Am Heart J,1993,125:1148-1154
7[9]Lindholm LH,Carlberg B,Samuelsson O.Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis.Lancet,2005,366:1545-1553
8[10]Poulter NR,Wedel H,Dahlof B,et al.Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes TrialBlood Pressure Lowering Arm (ASCOT-BPLA).Lancet,2005,366:907-913
二级参考文献4
1Hansson L, Zanchetti A, Carruthers G, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial.Lancet, 1998, 351:1755-1762.
2Hansson L, Zanchetti A, for the HOT Study Group. The Hypertension Optimal Treatment Study (the HOT Study).Blood Press, 1993,2:62-68.
3Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension.J Hypertens,1999,17:151-183.
4Hansson L, Zanchetti A, for the HOT Study Group. The Hypertension Optimal Treatment (HOT) Study-Patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Press, 1994,3:322-327.
